Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP591908.RAQr50ti4ukI3APrkp_HMM3Ozv1lZgbifDS_Hb2N2RppY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP591908.RAQr50ti4ukI3APrkp_HMM3Ozv1lZgbifDS_Hb2N2RppY130_assertion type Assertion NP591908.RAQr50ti4ukI3APrkp_HMM3Ozv1lZgbifDS_Hb2N2RppY130_head.
- NP591908.RAQr50ti4ukI3APrkp_HMM3Ozv1lZgbifDS_Hb2N2RppY130_assertion wasGeneratedBy ECO_0000203 NP591908.RAQr50ti4ukI3APrkp_HMM3Ozv1lZgbifDS_Hb2N2RppY130_provenance.
- NP591908.RAQr50ti4ukI3APrkp_HMM3Ozv1lZgbifDS_Hb2N2RppY130_assertion wasDerivedFrom befree-2016 NP591908.RAQr50ti4ukI3APrkp_HMM3Ozv1lZgbifDS_Hb2N2RppY130_provenance.
- NP591908.RAQr50ti4ukI3APrkp_HMM3Ozv1lZgbifDS_Hb2N2RppY130_assertion SIO_000772 17270454 NP591908.RAQr50ti4ukI3APrkp_HMM3Ozv1lZgbifDS_Hb2N2RppY130_provenance.
- NP591908.RAQr50ti4ukI3APrkp_HMM3Ozv1lZgbifDS_Hb2N2RppY130_assertion evidence source_evidence_literature NP591908.RAQr50ti4ukI3APrkp_HMM3Ozv1lZgbifDS_Hb2N2RppY130_provenance.
- NP591908.RAQr50ti4ukI3APrkp_HMM3Ozv1lZgbifDS_Hb2N2RppY130_assertion description "[We aimed to determine plasma and cerebrospinal fluid (CSF) levels of angiotensin-converting enzyme (ACE) and the soluble forms of intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1) and platelet endothelial cell adhesion molecule-1 (sPECAM-1) as surrogate markers for endothelial cell activation in clinically diagnosed patients with Alzheimer's disease (AD, n=260), dementia with Lewy bodies (DLB, n=39) and non-demented controls (n=34).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591908.RAQr50ti4ukI3APrkp_HMM3Ozv1lZgbifDS_Hb2N2RppY130_provenance.